Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amelogenins for Periodontal Defects After Third Molar Extraction
NCT04314726Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Mar 2016
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of amelogenin in periodontitis, sponsored by Sapienza University of Rome. Started Mar 2016; status: completed.
02
Drugs
amelogenin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04314726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04314726.